1457612 - Genocea Biosciences, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - GNCA (1457612)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
15 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P5+5+8+1+25
S1-3+0+0+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-07-24
GNCAPoole JonathanCFOM - OptEx$3.09+45,00039,247-782%+$139,050
D
2017-07-24
GNCAPoole JonathanCFOS - Sale+OE$6.00-45,00039,247-53%-$270,000
DM
2017-05-18
GNCASiber GeorgeDirM - OptEx$2.35+53,3322,017-104%+$125,078
DM
2017-05-18
GNCASiber GeorgeDirP - Purchase$6.04+53,3322,017-104%+$322,173
2017-05-03
GNCAPoole JonathanCFOA - Grant$0.00+31,74739,247+423%+$0-3
2017-05-10
GNCAPoole JonathanCFOF - Tax$6.13-3,50039,247-8%-$21,455-3
2017-05-08
GNCAPoole JonathanCFOS - Sale$6.51-6,21339,247-14%-$40,447-3
D
2016-11-09
GNCAHetherington Seth VChief Medical OfficerM - OptEx$2.02+5,00026,000+24%+$10,100+8+17+12+60
2016-11-07
GNCAPoole JonathanCFOP - Purchase$3.34+7,00017,213+69%+$23,380+8+17+12+60
M
2016-11-07
GNCAHoffman Eric SChief Business OfficerP - Purchase$3.49+7,00011,790+146%+$24,410+8+17+12+60
2016-11-07
GNCAClark William DPres, CEOP - Purchase$3.49+2,80052,205+6%+$9,772+8+17+12+60
2016-05-09
GNCAPoole JonathanCFOP - Purchase$3.88+4,0008,213+95%+$15,520-4-6+16-13
2015-12-16
GNCAClark William DPres, CEOP - Purchase$6.45+3,80043,607+10%+$24,510+5-7-46-41
D
2015-12-14
GNCAFlechtner Jessica BakerVP of ResearchM - OptEx$2.02+8,90610,787+473%+$17,990+5-1-45-36
D
2015-12-11
GNCAHetherington Seth VChief Medical OfficerM - OptEx$2.02+5,00021,000+31%+$10,100+5-1-45-36

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top